What type of study is this?

September 10, 2025European Heart Journal Supplements

A retrospective analysis of immunotherapy related myocarditis management at a UK tertiary hospital

View Full Paper

Ask AI

Bookmark

Authors

MHM. HadjiyiangouWeston Park Cancer Centre AHAmanda HodgsonEdith Cowan University AKAlan C. KwanCardiac Imaging

Discussion

Member takes

Implication

Retrospective analysis shows variable management of myocarditis in patients treated with immune checkpoint inhibitors, indicating a need for standardized guidelines.

Key Points

ICIs can cause myocarditis with a mortality rate of 47% amongst hospitalized patients, requiring hospitalization and immediate treatment.
17 patients identified with ICI-M had a mean age of 72, with underlying conditions like melanoma and lung cancer being common.
Key findings included high variability in cardiac biomarkers and treatments, with 89% presenting symptoms of cardiac failure.
The establishment of a cardio-oncology service is necessary to improve understanding and management of ICI-M through standardized protocols.

Cite This Study

Hadjiyiangou et al. (2025) studied this question.

synapsesocial.com/papers/68c1a5e554b1d3bfb60df260 https://doi.org/10.1093/eurheartjsupp/suaf083.143

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis shows variable management of myocarditis in patients treated with immune checkpoint inhibitors, indicating a need for standardized guidelines.

A retrospective analysis of immunotherapy related myocarditis management at a UK tertiary hospital

Discussion

Member takes

Implication

Key Points

Cite This Study

A retrospective analysis of immunotherapy related myocarditis management at a UK tertiary hospital

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider